Similar Stories to Roche To Take Over Genentech For $47 Billion on Bing News

GENEVA _ Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle with its U.S.-based cancer drug partner.

Topics:  geneva    swiss   roche   genentech    u.s    billion   
BING NEWS:
  • Roche and AC Immune's Alzheimer's drug on right track
    New data from Roche’s Genentech unit suggests that a phase 3 trial of Alzheimer’s drug crenezumab is on the right track, at an optimum dose for patients in early stages of the disease.
    12/27/2024 - 11:00 am | View Link
  • Roche puts $70m into ArsenalBio's programmable T-cell platform
    Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is ...
    12/27/2024 - 11:00 am | View Link
  • Kronos Bio Ends Collaboration with Genentech and Roche
    Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Kronos Bio ( (KRON) ) has shared an update.
    12/26/2024 - 10:30 pm | View Link
  • Genentech's Phase IIb Study Of Prasinezumab In Early-Stage Parkinson's Disease Misses Main Goal
    Genentech, a member of the Roche Group (RHHBY), announced that its phase IIb study of Prasinezumab in early-stage Parkinson's disease ...
    12/18/2024 - 6:41 pm | View Link
  • Genentech’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson’s Disease
    Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today results from the Phase IIb PADOVA study investigating prasinezumab in 586 people with early-stage Parkinson’s ...
    12/18/2024 - 4:03 pm | View Link
  • More
BING SEARCH:
  • Visit Us
    Following our March 2009 merger with Roche, Genentech's South San Francisco campus became the headquarters for Roche pharmaceutical operations in the United States. All of Genentech's U.S. sites are united by our goal of meeting the needs of patients.
    12/24/2024 - 12:16 am | View Website
  • Contact Us
    Medical information about Genentech products. Phone: (800) 821-8590 Chat with a nurse: Click here to chat Hours: Monday - Friday, 5am - 5pm PT. Clinical Trial Information. Information and support about Genentech sponsored Trials. Phone: (888) 662-6728 Hours: Monday - Friday, 5am - 5pm PT. Compassionate Use Information
    12/23/2024 - 6:11 pm | View Website
  • Medicines and Products
    Genentech has multiple medicines for serious and life-threatening medical conditions. Access information and resources on each of our medicines
    12/23/2024 - 1:18 pm | View Website
  • About Us
    Genentech's South San Francisco campus serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development continues to embrace the spirit of a “startup” and operates as a separate business unit within Roche.
    12/23/2024 - 3:09 am | View Website
  • Genentech: Press Releases | Monday, Apr 24, 2023
    Roche, Genentech and partners embark on global prevalence research, trend-spotting with digital analysis, and telehealth initiatives to assess & address deterrents to brain health to better understand holistic health journeys of patients with neurologic diseases
    12/20/2024 - 3:41 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News